Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Can B Corp. Discusses 2022 Growth Opportunities and New Partnerships on The Stock Day Podcast

CANB

Phoenix, Arizona--(Newsfile Corp. - April 20, 2022) - The Stock Day Podcast welcomed Can B Corp. (OTCQB: CANB) ("the Company"), a health & wellness company providing the highest quality hemp derived cannabinoid products, including under its own brands of Canbiola, Seven Chakras, NuWellness, Pure Leaf Oil and Duramed. CEO of the Company, Marco Alfonsi, joined Stock Day host Everett Jolly.

Jolly began the interview by asking about the Company's background and current projects. "Can B Corp. is a health and wellness company, and we have five operating divisions," shared Alfonsi, adding that the majority of revenues are currently being generated through three of these divisions. "Our first division is Pure Health Products," he explained. "We are now NSF approved which allows us the ability to bid for major drug and grocery chain store business for the first time."

"Our second operating division is the hemp division," continued Alfonsi. "For Q3 we made some major acquisitions," he shared. "We increased our balance sheet assets to over $16 million as of 12-31-2021," said Alfonsi. "We're able to be vertically integrated from biomass and hemp crude thru to isolate, and a full line of retain CBD products and various isomers."

"With our Miami operation, we have modeled a consumption lounge adjacent to our lab production operations and hope to open similar operations in select cities ove the next several months. "Once opened in locations where State and Federal laws allow, you'll be able to purchase CBD, Delta-8, or Delta-10 products, and still have the ability to enjoy them in a lounge, which in the evening will turn into a nightclub with live entertainment," he shared, adding that "the lounge will also serve infused beverages and have that CBD Experience being located adjacent to an actual production lab".

"Our third operating division is Duramed, which is our medical device company," said Alfonsi, before elaborating on the Company's wearable technology. "We are now in Michigan, where we have doubled our business," he shared, adding that the Company is also doing business in New York.

Jolly then commented on the Company's recently announced partnerships with PrimeX and American Development Partners. "In March, we signed the Brazilian Joint Venture with PrimeX," said Alfonsi, adding that CBD was not legal in Brazil until recently. "We have final products that are ready to be shipped to Brazil, and hopefully local physicians will be writing scripts on behalf of our products for their patients."

"With American Development Partners, it is a new concept for us," continued Alfonsi. "We were able to secure the American Development Partners to create and raise up to $200 million to build as many as 50 consumption lounges that are available to be assigned to our labs."

"What kind of new isomers are scheduled to be released within the next few months?" asked Jolly. "Right now we are able to do Delta-8," explained Alfonsi. "CBD is still a very low price, but once you convert that isolate into an isomer the price jumps," he explained, before elaborating on the different isomers. "We've been able to increase our revenues and margins for the simple reason that we are able to create these isomers."

To close the interview, Alfonsi elaborated on the Company's significant growth, and encouraged listeners and shareholders to keep up-to-date on their current plans and projects.

To hear Marco Alfonsi's entire interview, follow the link to the podcast here: https://audioboom.com/posts/8069795-can-b-corp-discusses-2022-growth-opportunities-and-new-partnerships-on-the-stock-day-podcast.

Investors Hangout is a proud sponsor of "Stock Day," and Stock Day Media encourages listeners to visit the company's message board at https://investorshangout.com/.

About Can B Corp.

Can B Corp. (OTCQB: CANB) is a health & wellness company providing the highest quality hemp derived cannabinoid products, including under its own brands of Canbiola, Seven Chakras, NuWellness, Pure Leaf Oil and Duramed. Can B utilizes multi-channel distribution to reach consumers, including medical facilities, doctor offices, retailers, online and direct. Can B Corp. operates R&D and production facilities in Lacey, WA, and Florida. To learn more about Can B Corp. and our comprehensive line of high quality products, please visit: Canbiola.com and www.CanBCorp.com, follow Can B Corp on Instagram and Facebook, or visit one of the 1,000+ retail outlets that carry Can B Corp. products.

For more information about Can B Corp., please visit: CanBCorp.com

Twitter @CanBCorp

Instagram @canbcorp

Facebook @ Can B Corp

YouTube

Forward-Looking Statements

Forward-looking statements and risks and uncertainties discussed in this release contain forward-looking statements. The words "anticipate," "believe," "estimate," "may," "intend," "expect," and similar expressions identify such forward-looking statements. Expected, actual results, performance, or achievements could differ materially from those contemplated, expressed, or implied by the forward-looking statements contained herein. Forward-looking statements are subject to a number of risks and uncertainties, including but not limited to, risks and uncertainties associated with, among other things, the impact of economic, competitive, and other factors affecting our operations, markets, products, and performance. The matters discussed herein should not be construed in any way, shape or manner of our future financial condition or stock price. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of latest information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

Investors and Media:
IR@canbiola.com
(917) 658-7878

About The "Stock Day" Podcast

Founded in 2013, Stock Day is the fastest growing media outlet for Nano-Cap and Micro-Cap companies. It educates investors while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued, under-sold Micro-Cap stocks of the market. Stock Day provides companies with customized solutions to their news distribution in both national and international media outlets. The Stock Day Podcast is the number one radio show of its kind in America.

SOURCE:
Stock Day Media
(602) 821-1102

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/121006